Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A289VV1
Wed, 21.06.2023
Haemato AG
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00.
Zusammenfassung:
Haemato hat das Jahr mit einem starken ersten Quartal begonnen und ist auf
gutem Weg, unsere Ziele fü [ … ]
Wed, 21.06.2023
Haemato AG
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 34,00.
Zusammenfassung:
Haemato hat das Jahr mit einem starken ersten Quartal begonnen und ist auf
gutem Weg, unsere Ziele fü [ … ]
Wed, 31.05.2023
HAEMATO AG
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result
In the first quarter of 2023, preliminary IFRS consolidated revenue increased by 25.3% to EUR 68.4 million compared to the same quarter of 2022 (EUR [ … ]
Wed, 31.05.2023
HAEMATO AG
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result
In the first quarter of 2023, preliminary IFRS consolidated revenue increased by 25.3% to EUR 68.4 million compared to the same quarter of 2022 (EUR [ … ]
Tue, 16.05.2023
HAEMATO AG
Dividend of EUR 1.20
Berlin, May 16, 2023 - At today's balance sheet meeting, the annual financial statements 2022 of HAEMATO AG, which were issued with an unqualified audit certificate, were adopted. The preliminary figures were confirmed. The Executive Board and Supervisory Board will propose a dividend of EUR 1.20 per dividend-bearing share to [ … ]
Tue, 16.05.2023
HAEMATO AG
Dividend of EUR 1.20
Berlin, May 16, 2023 - At today's balance sheet meeting, the annual financial statements 2022 of HAEMATO AG, which were issued with an unqualified audit certificate, were adopted. The preliminary figures were confirmed. The Executive Board and Supervisory Board will propose a dividend of EUR 1.20 per dividend-bearing share to [ … ]
Mon, 17.04.2023
HAEMATO AG
Preliminary 2023 figures: Revenue and earnings development in line with
expectations; Guidance issued against the backdrop of increased mandatory
discounts; Target price: € 31.70; Rating: BUY
According to preliminary figures, HAEMATO AG had to accept a decline in
turnover of 12.9% to € 248.2 million (previous year: € 285.0 mi [ … ]
Mon, 17.04.2023
HAEMATO AG
Preliminary 2023 figures: Revenue and earnings development in line with
expectations; Guidance issued against the backdrop of increased mandatory
discounts; Target price: € 31.70; Rating: BUY
According to preliminary figures, HAEMATO AG had to accept a decline in
turnover of 12.9% to € 248.2 million (previous year: € 285.0 mi [ … ]
Thu, 13.04.2023
Haemato AG
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 33,00.
Zusammenfassung:
Die vorläufigen Zahlen zeigten eine gute Rentabilität trotz des Wegfalls
des Corona-Testgeschäfts, da [ … ]
Thu, 13.04.2023
Haemato AG
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 33,00.
Zusammenfassung:
Die vorläufigen Zahlen zeigten eine gute Rentabilität trotz des Wegfalls
des Corona-Testgeschäfts, da [ … ]